Latest Proof Of Concept News

Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.

Papyrus Australia has appointed Daniel Schmidt as CEO and secured a $250k government grant alongside a binding agreement to produce biodegradable mining products, marking a decisive shift from R&D to commercial operations.

InFocus Group Holdings has launched a dedicated iGaming business unit, aiming to capitalize on the booming $95 billion online gaming industry with key contracts and digital asset integration.

S2 Resources is set to begin diamond drilling within weeks at its Warraweena project in northern New South Wales, following promising historical drill results and an ongoing gravity survey extension. The project targets multiple mineralisation styles, including gold, copper, nickel, and base metals.

HeraMED is fast-tracking its AI-driven maternity care technologies, including an early release of its AI Clinician Assistant and predictive models for high-risk pregnancies, aiming to revolutionize digital women’s health globally.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

icetana Limited reveals delays and payment uncertainties in its Baghdad Safe City project, raising questions about revenue timing and project execution.

Surefire Resources has identified a significant bedrock conductor at its Copper Hill Project through a recent ground electromagnetic survey, marking a promising step in its copper exploration efforts. This discovery aligns with previous geochemical anomalies and will shape upcoming drilling programs.

PYC Therapeutics has completed dosing in its Phase 1 study of PYC-001 for Autosomal Dominant Optic Atrophy, showing strong safety and early signs of improved vision. The company plans to launch a global Phase 1/2 trial later this year.

BPH Global has secured a 12-month Master Services Agreement with Singapore’s Marchwood Laboratory Services to enhance its research on extracting rare earth elements from seaweed, focusing on four critical metals vital to clean energy and technology.

Dotz Nano Limited reported a reduced half-year loss and significant progress in its Direct Air Capture technology, while navigating funding uncertainties with key investors.

Singular Health Group reported a $6.38 million loss for FY2025 while securing a pivotal $1.3 million commercial agreement with US-based Provider Network Solutions to deploy its 3DICOM software. The company also completed a major cloud migration of its platform, positioning itself for growth in the US healthcare market.